Company Profile
Cyclerion Stock Price, News & Analysis
- Ticker:
- CYCN
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
3.56 USD (+0.28%)
Close
Last updated: August 6, 2026
13.1M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, CYCN closed up 0.28% at $3.56. No new same-company headline was identified in the current news window.
Company overview
Business overview
Cyclerion was a biotechnology company focused on cyclic nucleotide biology and central nervous system or vascular-related disease programs before becoming a historical ticker. Its story reflected the challenge of turning a mechanistic platform into a durable drug franchise.
Geographic Base and Sector Classification
Cyclerion was headquartered in the United States and traded on NASDAQ. It sat in the development-stage biotechnology segment.
Business Model Characteristics
The business depended on clinical validation, strategic focus, and capital efficiency. Investors historically watched whether the platform could produce differentiated medicines in a difficult field.
Position Within the Biotechnology Landscape
Cyclerion belongs to the historical platform-biotech set. Like many early scientific names, its stock depended on data and the market's patience for development risk.
Future catalysts
Cyclerion is now largely a legacy and closeout story, so the catalysts are any strategic or asset-disposition update rather than a live pipeline event. The market is mainly waiting for clarity on remaining value.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Cyclerion (CYCN)?
Cyclerion (CYCN) most recently closed at 3.56 USD, a +0.28% move versus the previous session.
What is the market cap of Cyclerion (CYCN)?
Cyclerion currently has a market capitalization of 13.1M USD on BioPharmSignal.
What does Cyclerion do?
Cyclerion was a biotechnology company focused on cyclic nucleotide biology and central nervous system or vascular-related disease programs before becoming a historical ticker. Its story reflected the challenge of turning a mechanistic platform into a durable drug franchise.
On which exchange is CYCN stock listed?
Cyclerion (CYCN) is associated with NASDAQ, United States, Biopharma.
What is Cyclerion?
Cyclerion is now largely a legacy and closeout story, so the catalysts are any strategic or asset-disposition update rather than a live pipeline event.
Which conditions is Cyclerion targeting with Cyclerion?
Cyclerion is now largely a legacy and closeout story, so the catalysts are any strategic or asset-disposition update rather than a live pipeline event.
How does Cyclerion describe recent progress with Cyclerion?
Cyclerion is now largely a legacy and closeout story, so the catalysts are any strategic or asset-disposition update rather than a live pipeline event.
What future catalysts are investors watching for Cyclerion?
Cyclerion is now largely a legacy and closeout story, so the catalysts are any strategic or asset-disposition update rather than a live pipeline event. The market is mainly waiting for clarity on remaining value.